GLYCODISPLAY

GlycoDisplay develops novel biopharmaceuticals by modifying sugars. The proprietary technology applies targeted cell engineering to display different glycans on cells and proteins. GlycoDisplay is a spin-out from University of Copenhagen, Center for Glycomics, which is world leading within the field of glyco-engineering and glycomics... GlycoDisplay Aps was founded 2016 by Professor Henrik Clausen and four cofounders from Copenhagen Center for Glycomics at University of Copenhagen. The team has extensive experience with research in Glycomics, glycoengineering of mammalian cell lines and industry know-how on the development of biologics.

Also known as: GlycoDisplay Aps, GLYCODISPLAY.COM

Registration numbers: DK 38218603 (W)

Primary location: Copenhagen